D
DuoGenic StemCells Corp
TPEX:7607
DuoGenic StemCells Corp
TPEX:7607
Price:
8.3
TWD
-2.35%
Market Cap:
NT$253.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
DuoGenic StemCells Corp
TPEX:7607
|
TW |
|
P
|
Prodigy PCL
SET:PDG
|
TH |
|
Superkrane Mitra Utama Tbk PT
IDX:SKRN
|
ID |
|
Leroy Seafood Group ASA
F:Z1L0
|
NO |
|
Arkha Jayanti Persada Tbk PT
IDX:ARKA
|
ID |
|
N
|
NTF Intergroup (Thailand) PCL
SET:NTF
|
TH |
|
BFI Finance Indonesia Tbk PT
IDX:BFIN
|
ID |
Company Overview
Business Description
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Headquarters
- Taiwan TW
- Employees
- 25
- IPO date
- May 25, 2023
Duogenic Stemcells Corp. engages in the provision of biotechnology and medical care services. The company is headquartered in Taichung, Taichung and currently employs 25 full-time employees. The company went IPO on 2023-05-25. The culture medium provides the nutrients and raw materials needed for cell growth and reproduction. The cell separator set is used to draw peripheral blood to purify and isolate mononuclear cells. Products include mesenchymal stem cell culture media, endothelial cell culture media, closed cell separation operating devices and others. Products are mainly sold in Taiwan, Asia, and North America.